Skip to main content
Top
Published in: Cancer Cell International 1/2015

Open Access 01-12-2015 | Primary research

Kinetic characterization of lactate dehydrogenase in normal and malignant human breast tissues

Authors: Abdolhassan Talaiezadeh, Ali Shahriari, Mohammad Reza Tabandeh, Payam Fathizadeh, Siavash Mansouri

Published in: Cancer Cell International | Issue 1/2015

Login to get access

Abstract

Background

Aerobic glycolysis rate is higher in breast cancer tissues than adjacent normal tissues which providethe ATP, lactate and anabolic precursors required for tumourgenesis and metastasis. Lactate dehydrogenase (LDH) is a critical enzyme during aerobic glycolysis as it is typically responsible for the production of lactate and regeneration of NAD+, which allows for the continued functioning of glycolysis even in the absence of oxygen. LDH has been found to be highly expressed in breast tumors. Enzyme kinetic characteristics is related to environmentinvolving the enzyme, and tumor microenvironment has distinct features relative to adjacent normal tissues, thus we hypothesized that LDH should have different kinetic characteristics in breast tumors compared to normal breast tissues.

Methods

LDH was partially purifiedfrom human breast tumors and normal tissues, which were obtained directly from operating room. TheMichaelis-Menten constant (Km), maximum velocity (Vmax), activation energy (Ea) and enzyme efficiency in breast tumors and normal tissueswere determined.

Results

It was found that tumor LDH affinity in forward reaction was the same as normal LDH but Vmax of cancerous LDH was higher relative to normal LDH. In reverse reaction, affinity of tumor LDH for lactate and NAD+ was lower than normal LDH, also enzyme efficiency for lactate and NAD+ was higher in normal samples. The Ea of reverse reaction was higher in cancerous tissues.

Conclusions

It was concluded that thelow LDH affinity for lactate and NAD+ is a valuable tool for preserving lactate by cancer cells. We also conclude that increasing of LDH affinity may be a valid molecular target to abolish lactate dependent tumor growth and kinetic characteristics of LDH could be a novel diagnostic parameter for human breast cancer.
Literature
1.
2.
go back to reference Murray RK, Bender DA, Botham KM, Kennelly PJ, Rodwell VW, Anthony Weil P. Harper’s illustrated biochemistry. 27th ed. USA: Lange Medical Books/MacGraw-Hill Companies; 2006. Murray RK, Bender DA, Botham KM, Kennelly PJ, Rodwell VW, Anthony Weil P. Harper’s illustrated biochemistry. 27th ed. USA: Lange Medical Books/MacGraw-Hill Companies; 2006.
4.
go back to reference Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer. 2004;4:891–9.CrossRefPubMed Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer. 2004;4:891–9.CrossRefPubMed
5.
go back to reference Rofstad EK, Mathiesen B, Kindem K, Galappathi K. Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Cancer Res. 2006;66:6699–707.CrossRefPubMed Rofstad EK, Mathiesen B, Kindem K, Galappathi K. Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Cancer Res. 2006;66:6699–707.CrossRefPubMed
6.
go back to reference Dakubo GD. Mitochondria genetic and cancer. 1st ed. England: Springer; 2010.CrossRef Dakubo GD. Mitochondria genetic and cancer. 1st ed. England: Springer; 2010.CrossRef
7.
go back to reference Levine AJ, Puzio-Kuter AM. The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science. 2010;330:1340–4.CrossRefPubMed Levine AJ, Puzio-Kuter AM. The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science. 2010;330:1340–4.CrossRefPubMed
8.
go back to reference Markert CL. Lactate dehydrogenase isozymes: dissociation and recombination of subunits. Science. 1963;140:1329–30.CrossRefPubMed Markert CL. Lactate dehydrogenase isozymes: dissociation and recombination of subunits. Science. 1963;140:1329–30.CrossRefPubMed
9.
go back to reference Koukourakis MI, Giatromanolaki A, Simopoulos C, Polychronidis A, Sivridis E. Lactate dehydrogenase 5 (LDH5) relates to up-regulated hypoxia inducible factor pathway and metastasis in colorectal cancer. Clin Exp Metastasis. 2005;22:25–30.CrossRefPubMed Koukourakis MI, Giatromanolaki A, Simopoulos C, Polychronidis A, Sivridis E. Lactate dehydrogenase 5 (LDH5) relates to up-regulated hypoxia inducible factor pathway and metastasis in colorectal cancer. Clin Exp Metastasis. 2005;22:25–30.CrossRefPubMed
10.
go back to reference Koukourakis MI, Kontomanolis E, Giatromanolaki A, Sivridis E, Liberis V. Serum and tissue LDH levels in patients with breast/gynaecological cancer and benign diseases. Gynecol Obstet Invest. 2009;67:162–8.CrossRefPubMed Koukourakis MI, Kontomanolis E, Giatromanolaki A, Sivridis E, Liberis V. Serum and tissue LDH levels in patients with breast/gynaecological cancer and benign diseases. Gynecol Obstet Invest. 2009;67:162–8.CrossRefPubMed
11.
go back to reference Balinsky D, Platz CE, Lewis JW. Isozyme patterns of normal, benign, and malignant human breast tissues. Cancer Res. 1983;43:5895–901.PubMed Balinsky D, Platz CE, Lewis JW. Isozyme patterns of normal, benign, and malignant human breast tissues. Cancer Res. 1983;43:5895–901.PubMed
12.
go back to reference Rong Y, Wu W, Ni X, Kuang T, Jin D, Wang D, et al. Lactate dehydrogenase A is overexpressed in pancreatic cancer and promotes the growth of pancreatic cancer cells. Tumor Biol. 2013;34(3):1523–30.CrossRef Rong Y, Wu W, Ni X, Kuang T, Jin D, Wang D, et al. Lactate dehydrogenase A is overexpressed in pancreatic cancer and promotes the growth of pancreatic cancer cells. Tumor Biol. 2013;34(3):1523–30.CrossRef
13.
go back to reference Dennison JB, Molina JR, Mitra S, Gonzalez-Angulo AM, Balko JM, Kuba MJ, et al. Lactate dehydrogenase B: a metabolic marker of response to neoadjuvant chemotherapy in breast cancer. Clin Cancer Res. 2013;19:3703–13.CrossRefPubMedCentralPubMed Dennison JB, Molina JR, Mitra S, Gonzalez-Angulo AM, Balko JM, Kuba MJ, et al. Lactate dehydrogenase B: a metabolic marker of response to neoadjuvant chemotherapy in breast cancer. Clin Cancer Res. 2013;19:3703–13.CrossRefPubMedCentralPubMed
14.
go back to reference Shahriari A, Dawson NJ, Bell RAV, Storey KB. Stable suppression of lactate dehydrogenase activityduring anoxia in the foot muscle of littorinalittorea andthe potential role of acetylation as a novel posttranslationalregulatory mechanism. Enzyme Res. 2013;2013:461374.CrossRefPubMedCentralPubMed Shahriari A, Dawson NJ, Bell RAV, Storey KB. Stable suppression of lactate dehydrogenase activityduring anoxia in the foot muscle of littorinalittorea andthe potential role of acetylation as a novel posttranslationalregulatory mechanism. Enzyme Res. 2013;2013:461374.CrossRefPubMedCentralPubMed
15.
go back to reference Brooks SPJA. Simple computer program with statistical tests for the analysis of enzyme kinetics. Biotechniques. 1992;13:906–11.PubMed Brooks SPJA. Simple computer program with statistical tests for the analysis of enzyme kinetics. Biotechniques. 1992;13:906–11.PubMed
16.
go back to reference Brooks SPJA. Program for analyzing enzyme rate data obtained from a microplate reader. Biotechniques. 1994;17:1155–61. Brooks SPJA. Program for analyzing enzyme rate data obtained from a microplate reader. Biotechniques. 1994;17:1155–61.
17.
go back to reference DeBeradinis RJ. Is cancer a disease of abnormal cellular metabolism? New angles on an old idea. Genet Med. 2008;10:767–77.CrossRef DeBeradinis RJ. Is cancer a disease of abnormal cellular metabolism? New angles on an old idea. Genet Med. 2008;10:767–77.CrossRef
19.
go back to reference De Bari L, Chieppa G, Marra E, Passarella S. L-lactate metabolism can occur in normal and cancer prostate cells via the novel mitochondrial L-lactate dehydrogenase. Int J of Oncol. 2010;37:1607–20. De Bari L, Chieppa G, Marra E, Passarella S. L-lactate metabolism can occur in normal and cancer prostate cells via the novel mitochondrial L-lactate dehydrogenase. Int J of Oncol. 2010;37:1607–20.
20.
go back to reference Pizzuto R, Paventi G, Porcile C, Sarnataro D, Daniele A, Passarella S. L-Lactate metabolism in HEP G2 cell mitochondria due to the L-lactate dehydrogenase determines the occurrence of the lactate/pyruvate shuttle and the appearance of oxaloacetate, malate and citrate outside mitochondria. Biochim Biophys Acta. 2010;1817:1679–90.CrossRef Pizzuto R, Paventi G, Porcile C, Sarnataro D, Daniele A, Passarella S. L-Lactate metabolism in HEP G2 cell mitochondria due to the L-lactate dehydrogenase determines the occurrence of the lactate/pyruvate shuttle and the appearance of oxaloacetate, malate and citrate outside mitochondria. Biochim Biophys Acta. 2010;1817:1679–90.CrossRef
21.
go back to reference Fukuruma DK, Jain R. Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize. J Cell Biochem. 2007;101:937–49.CrossRef Fukuruma DK, Jain R. Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize. J Cell Biochem. 2007;101:937–49.CrossRef
22.
go back to reference Markert CL. Lactate dehydrogenase, biochemistry and function of lactate dehydrogenase. Cell Biochem Function. 1984;2:131–4.CrossRef Markert CL. Lactate dehydrogenase, biochemistry and function of lactate dehydrogenase. Cell Biochem Function. 1984;2:131–4.CrossRef
23.
go back to reference Brown JM, Giaccia AJ. The unique physiology of solid tumors: Opportunities (and problems) for cancer therapy. Cancer Res. 1998;58:1408–16.PubMed Brown JM, Giaccia AJ. The unique physiology of solid tumors: Opportunities (and problems) for cancer therapy. Cancer Res. 1998;58:1408–16.PubMed
24.
25.
go back to reference Wigfield SM, Winter SC, Giatromanolaki A, Taylor J, Koukourakis ML, Harris AL. PDK-1 regulates lactate production in hypoxia and is associated with poor prognosis in head and neck squamous cancer. Br J Cancer. 2008;98:1975–84.CrossRefPubMedCentralPubMed Wigfield SM, Winter SC, Giatromanolaki A, Taylor J, Koukourakis ML, Harris AL. PDK-1 regulates lactate production in hypoxia and is associated with poor prognosis in head and neck squamous cancer. Br J Cancer. 2008;98:1975–84.CrossRefPubMedCentralPubMed
26.
go back to reference Thangaraju M, Carswell KN, Prasad PD, Ganapathy V. Colon cancer cells maintain low levels of pyruvate to avoid cell death caused by inhibition of HDAC1/HDAC3. Biochem J. 2009;417:379–89.CrossRefPubMed Thangaraju M, Carswell KN, Prasad PD, Ganapathy V. Colon cancer cells maintain low levels of pyruvate to avoid cell death caused by inhibition of HDAC1/HDAC3. Biochem J. 2009;417:379–89.CrossRefPubMed
27.
go back to reference Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer. 2011;11:85–95.CrossRefPubMed Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer. 2011;11:85–95.CrossRefPubMed
28.
go back to reference Hirschhaeuser F, Salter UGA, Mueller-Klieser W. Lactate: a metabolic key player in cancer. Cancer Res. 2011;71:6921–5.CrossRefPubMed Hirschhaeuser F, Salter UGA, Mueller-Klieser W. Lactate: a metabolic key player in cancer. Cancer Res. 2011;71:6921–5.CrossRefPubMed
29.
go back to reference Beckert S, Farrahi F, Aslam RS, Scheuenstuhl H, Konigsrainer A, ZamirulHussain M, et al. Lactate stimulates endothelial cell migration. Wound Repair Regen. 2006;14:321–4.CrossRefPubMed Beckert S, Farrahi F, Aslam RS, Scheuenstuhl H, Konigsrainer A, ZamirulHussain M, et al. Lactate stimulates endothelial cell migration. Wound Repair Regen. 2006;14:321–4.CrossRefPubMed
30.
go back to reference Walenta S, Mueller-Klieser WF. Lactate: mirror and motor of tumor malignancy. Semin Radiat Oncol. 2004;14(3):267–74.CrossRefPubMed Walenta S, Mueller-Klieser WF. Lactate: mirror and motor of tumor malignancy. Semin Radiat Oncol. 2004;14(3):267–74.CrossRefPubMed
31.
go back to reference Brizel DM, Schroeder T, Scher RL, Walenta S, Clough RW, Dewhirst MW, et al. Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int J Radiat Oncol Biol Physics. 2001;51(2):349–53.CrossRef Brizel DM, Schroeder T, Scher RL, Walenta S, Clough RW, Dewhirst MW, et al. Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int J Radiat Oncol Biol Physics. 2001;51(2):349–53.CrossRef
32.
go back to reference Walenta S, Wetterling M, Lehrke M, Schwickert G, Sundfor K, Rofstad EK, et al. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res. 2000;60:916–21.PubMed Walenta S, Wetterling M, Lehrke M, Schwickert G, Sundfor K, Rofstad EK, et al. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res. 2000;60:916–21.PubMed
33.
go back to reference Bell RAV, Storey KB. Regulation of liver glutamate dehydrogenase by reversible phosphorylation in a hibernating mammal. Comp Biochem Physiol, Part B. 2010;157:310–6.CrossRef Bell RAV, Storey KB. Regulation of liver glutamate dehydrogenase by reversible phosphorylation in a hibernating mammal. Comp Biochem Physiol, Part B. 2010;157:310–6.CrossRef
34.
go back to reference Porporato PE, Dhup S, Dadhich RK, Copetti T, Sonveaux P. Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review. Frontiers Pharmacol. 2011;2(49):1–18. Porporato PE, Dhup S, Dadhich RK, Copetti T, Sonveaux P. Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review. Frontiers Pharmacol. 2011;2(49):1–18.
Metadata
Title
Kinetic characterization of lactate dehydrogenase in normal and malignant human breast tissues
Authors
Abdolhassan Talaiezadeh
Ali Shahriari
Mohammad Reza Tabandeh
Payam Fathizadeh
Siavash Mansouri
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Cancer Cell International / Issue 1/2015
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/s12935-015-0171-7

Other articles of this Issue 1/2015

Cancer Cell International 1/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine